EUVIMEDEUVIMED entdecken
Crossref

Discovery of selective PARP1/CDK6 dual target inhibitors modulating Wnt signaling pathway for the treatment of TNBC

Yiling Lai, Keying Zheng, Heqing Fan, Jingting Zeng, Yongwei Fan, Na Li, Fanglan Liu, Chunhua Xia, Cheng Wang

Bioorganic Chemistry · 2026-06 · 174 · 109698

DOI: 10.1016/j.bioorg.2026.109698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-06. Verfasst von Yiling Lai und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330031, People's Republic of China. Hauptthemen laut MEDLINE: Poly (ADP-Ribose) Polymerase-1, Antineoplastic Agents, Wnt Signaling Pathway, Poly(ADP-ribose) Polymerase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Jiangxi Provincial Natural Science Foundation, National Natural Science Foundation of China, Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The combination of PARP1 and CDK6 inhibitors shows synergistic anticancer effects in TNBC. However, first-generation PARP inhibitors lack optimal PARP trapping efficiency and enzyme family selectivity, often leading to hematotoxicity. Herein, we report the rational design and synthesis of a series of second-generation selective PARP1/CDK6 dual inhibitors, based on the structural features of the latest selective PARP1 inhibitor AZD5305. Among these, PC8 exhibits potent dual inhibition of PARP1 (IC50 = 0.126 μM) and CDK6 (IC50 = 0.197 μM), showing selectivity over PARP2 (IC50 = 0.824 μM). PC8 effectively inhibits the proliferation and migration of TNBC cells, and induces intracellular ROS accumulation, thereby exacerbating mitochondrial dysfunction and DNA damage. Additionally, it modulates the classical Wnt signaling pathway. Furthermore, compared with first-generation inhibitors, PC8 displays improved metabolic stability in liver microsomes. As a novel selective PARP1/CDK6 dual inhibitor with improved pharmacological properties, PC8 represents a promising lead structure for further optimization of second-generation PARP1/CDK6 dual inhibitors for the treatment of TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly (ADP-Ribose) Polymerase-1Antineoplastic AgentsWnt Signaling PathwayPoly(ADP-ribose) Polymerase InhibitorsCyclin-Dependent Kinase 6Drug DiscoveryProtein Kinase InhibitorsHumansStructure-Activity RelationshipCell ProliferationDrug Screening Assays, AntitumorMolecular StructureDose-Response Relationship, DrugCell Line, Tumor

Stichwörter der Autor:innen

CDK6Dual inhibitorMitochondrial damagePARP1TNBCWnt

Substanzen

Poly (ADP-Ribose) Polymerase-1Antineoplastic AgentsPoly(ADP-ribose) Polymerase InhibitorsCyclin-Dependent Kinase 6PARP1 protein, humanCDK6 protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330031, People's Republic of China.
  • School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330031, People's Republic of China; Key Laboratory of New Drug Transformation and Evaluation of Jiangxi Province, Nanchang, Jiangxi 330…

Förderung

  • Jiangxi Provincial Natural Science Foundation
  • National Natural Science Foundation of China
  • Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province

Zitieren

APA

Lai, Y., Zheng, K., Fan, H., Zeng, J., Fan, Y., Li, N., Liu, F., Xia, C., & Wang, C. (2026). Discovery of selective PARP1/CDK6 dual target inhibitors modulating Wnt signaling pathway for the treatment of TNBC. Bioorganic Chemistry, 174, 109698. https://doi.org/10.1016/j.bioorg.2026.109698

Vancouver

Lai Y, Zheng K, Fan H, Zeng J, Fan Y, Li N, et al. Discovery of selective PARP1/CDK6 dual target inhibitors modulating Wnt signaling pathway for the treatment of TNBC. Bioorganic Chemistry. 2026;174:109698. doi:10.1016/j.bioorg.2026.109698

BibTeX
@article{Lai2026,
  author = {Lai, Yiling and Zheng, Keying and Fan, Heqing and Zeng, Jingting and Fan, Yongwei and Li, Na and Liu, Fanglan and Xia, Chunhua and Wang, Cheng},
  title = {Discovery of selective PARP1/CDK6 dual target inhibitors modulating Wnt signaling pathway for the treatment of TNBC},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {174},
  pages = {109698},
  doi = {10.1016/j.bioorg.2026.109698}
}
Kostenlos starten →